Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DH
HOLDDefinitive Healthcare Corp. · Healthcare · United States · $72M · Avg Vol: $326K/d
COMPANY DESCRIPTION
Definitive Healthcare Corp. delivers comprehensive healthcare commercial intelligence data and analytics to a broad client base, including pharmaceutical, medical device, and healthcare provider organizations. The company's proprietary platform provides granular insights into healthcare professionals, facilities, and market trends, acting as a crucial decision-support tool. It is a market leader in health information services, distinguished by its extensive data coverage and advanced analytical capabilities that drive high customer retention.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 222.7M | 251.4M | 252.2M | 241.5M | 2.7% | 238.3M | 223.5M | 222.8M | -4.0% |
| EPS | -0.06 | -1.79 | -3.54 | -1.30 | — | -1.63 | — | — | — |
| Shares | 105.1M | 116.6M | 114.0M | 104.0M | -1.1% | 105.5M | — | — | — |
| Debt | 275.8M | 267.9M | 253.1M | 172.7M | -14.5% | 169.8M | — | — | — |
| Equity | 948.9M | 861.4M | 444.4M | 281.1M | -33.3% | — | — | — | — |
| Op CF | 35.6M | 41.2M | 58.2M | 53.8M | 14.8% | 39.3M | — | — | — |
| Inv CF | -248.9M | -31.8M | -26.4M | 153.9M | — | — | — | — | — |
| Fin CF | -26.7M | -25.6M | -56.7M | -150.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DH | Definitive Healthcare Corp.(you) | $72M | 40 | HOLD |
| HCAT | Health Catalyst, Inc. | $154M | 37 | HOLD |
| LFMD | LifeMD, Inc. | $179M | 32 | SELL |
| DRIO | DarioHealth Corp. | $57M | 16 | STRONG SELL |
| NURS.V | Hydreight Technologies Inc. | $167M | 55 | HOLD |
| CTEV | Claritev Corporation | $368M | 40 | HOLD |
| M7T.AX | Mach7 Technologies Limited | $54M | 12 | STRONG SELL |
| EVH | Evolent Health, Inc. | $475M | 44 | HOLD |
| CARL | Carlsmed, Inc. | $294M | 24 | SELL |
| AMWL | American Well Corporation | $181M | 67 | BUY |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%